Form 4: Varonis CFO Sells 10,400 Shares Under 10b5-1 Plan
Insider Transaction Report
Varonis Systems CFO and COO Guy Melamed sold 10,400 shares of common stock for approximately $59.53 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Guy Melamed, CFO and COO of Varonis Systems Inc. (VRNS), reported a sale of company common stock.
- The transaction involved the disposition of 10,400 shares of common stock.
- The shares were sold at a weighted average price of $59.53 per share, with individual transactions ranging from $59.50 to $59.57.
- The sale was executed on August 22, 2025.
- This transaction was conducted under a Rule 10b5-1 trading plan, which Mr. Melamed adopted in 2024.
- Following this sale, Mr. Melamed directly beneficially owns 417,497 shares of Varonis Systems Inc. common stock.
Sentiment
Score: 5
Explanation: The sale of shares by a key executive is a neutral event as it was conducted under a pre-arranged Rule 10b5-1 trading plan, which typically indicates a planned liquidity event rather than a reaction to new material non-public information.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than an immediate reaction to new information.
Negatives
- An insider sale, even if pre-planned, reduces the insider's direct ownership in the company.
Future Outlook
This Form 4 filing reports a past insider transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing reports an individual insider transaction and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders may view the insider sale as a slight negative, although this is mitigated by the pre-planned nature of the transaction under a Rule 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 2024 | Rule 10b5-1 trading plan adopted by Guy Melamed. |
| 08/22/2025 | Date of common stock transaction (sale). |
| 08/26/2025 | Date Form 4 was signed. |
Recommendation
holdThe reported transaction is a routine insider sale executed under a pre-established Rule 10b5-1 trading plan. Such planned sales are generally not indicative of a change in the company's fundamental outlook or the insider's confidence, and therefore, do not typically warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate the company based on its financial performance, strategic initiatives, and broader market conditions.
Keywords
Varonis Systems, VRNS, Insider Trading, Form 4, Guy Melamed, CFO, COO, Stock Sale, 10b5-1 Plan, Equity Disposition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.